title: SSRI use during pregnancy.
abstract: The Society of Maternal and Fetal Medicine recently had a conference on the use of medications during pregnancy, delivery, and breast-feeding. One of the most important topics covered during that 2-day conference was major depression (MDD) and the use of Serotonin Selective Reuptake Inhibitors (SSRIs). This article will review the current state of knowledge about MDD during and immediately after pregnancy and treatment with SSRIs during pregnancy and breast-feeding.
authors.affiliation: Division of Psychology & Behavioral Health, Children's National Health Systems, 111 Michigan Ave, NW Washington, DC 20010. Electronic address: htran@childrensnational.org.
authors.forename: Heather
authors.initials: H
authors.lastname: Tran
authors.affiliation: Division of Psychology & Behavioral Health, Children's National Health Systems, 111 Michigan Ave, NW Washington, DC 20010.
authors.forename: Adelaide S
authors.initials: AS
authors.lastname: Robb
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D001942:Breast Feeding; D019052:Depression, Postpartum / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D011263:Pregnancy Trimester, Third; D037841:Pregnant People / Q000523:psychology; D011297:Prenatal Exposure Delayed Effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics*; D012955:Societies, Medical
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors